Cargando…
Current Status and Prospects of Targeted Therapy for Osteosarcoma
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS prognosis is poor, and improving the survival of OS patients remains a challenge. Current treatment methods such as surgical appr...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653755/ https://www.ncbi.nlm.nih.gov/pubmed/36359903 http://dx.doi.org/10.3390/cells11213507 |
_version_ | 1784828759317151744 |
---|---|
author | Hu, Zunguo Wen, Shuang Huo, Zijun Wang, Qing Zhao, Jiantao Wang, Zihao Chen, Yanchun Zhang, Lingyun Zhou, Fenghua Guo, Zhangyu Liu, Huancai Zhou, Shuanhu |
author_facet | Hu, Zunguo Wen, Shuang Huo, Zijun Wang, Qing Zhao, Jiantao Wang, Zihao Chen, Yanchun Zhang, Lingyun Zhou, Fenghua Guo, Zhangyu Liu, Huancai Zhou, Shuanhu |
author_sort | Hu, Zunguo |
collection | PubMed |
description | Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS prognosis is poor, and improving the survival of OS patients remains a challenge. Current treatment methods such as surgical approaches, chemotherapeutic drugs, and immunotherapeutic drugs remain ineffective. As research progresses, targeted therapy is gradually becoming irreplaceable. In this review, several treatment modalities for osteosarcoma, such as surgery, chemotherapy, and immunotherapy, are briefly described, followed by a discussion of targeted therapy, the important targets, and new technologies for osteosarcoma treatment. |
format | Online Article Text |
id | pubmed-9653755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96537552022-11-15 Current Status and Prospects of Targeted Therapy for Osteosarcoma Hu, Zunguo Wen, Shuang Huo, Zijun Wang, Qing Zhao, Jiantao Wang, Zihao Chen, Yanchun Zhang, Lingyun Zhou, Fenghua Guo, Zhangyu Liu, Huancai Zhou, Shuanhu Cells Review Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS prognosis is poor, and improving the survival of OS patients remains a challenge. Current treatment methods such as surgical approaches, chemotherapeutic drugs, and immunotherapeutic drugs remain ineffective. As research progresses, targeted therapy is gradually becoming irreplaceable. In this review, several treatment modalities for osteosarcoma, such as surgery, chemotherapy, and immunotherapy, are briefly described, followed by a discussion of targeted therapy, the important targets, and new technologies for osteosarcoma treatment. MDPI 2022-11-05 /pmc/articles/PMC9653755/ /pubmed/36359903 http://dx.doi.org/10.3390/cells11213507 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hu, Zunguo Wen, Shuang Huo, Zijun Wang, Qing Zhao, Jiantao Wang, Zihao Chen, Yanchun Zhang, Lingyun Zhou, Fenghua Guo, Zhangyu Liu, Huancai Zhou, Shuanhu Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title | Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title_full | Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title_fullStr | Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title_full_unstemmed | Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title_short | Current Status and Prospects of Targeted Therapy for Osteosarcoma |
title_sort | current status and prospects of targeted therapy for osteosarcoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653755/ https://www.ncbi.nlm.nih.gov/pubmed/36359903 http://dx.doi.org/10.3390/cells11213507 |
work_keys_str_mv | AT huzunguo currentstatusandprospectsoftargetedtherapyforosteosarcoma AT wenshuang currentstatusandprospectsoftargetedtherapyforosteosarcoma AT huozijun currentstatusandprospectsoftargetedtherapyforosteosarcoma AT wangqing currentstatusandprospectsoftargetedtherapyforosteosarcoma AT zhaojiantao currentstatusandprospectsoftargetedtherapyforosteosarcoma AT wangzihao currentstatusandprospectsoftargetedtherapyforosteosarcoma AT chenyanchun currentstatusandprospectsoftargetedtherapyforosteosarcoma AT zhanglingyun currentstatusandprospectsoftargetedtherapyforosteosarcoma AT zhoufenghua currentstatusandprospectsoftargetedtherapyforosteosarcoma AT guozhangyu currentstatusandprospectsoftargetedtherapyforosteosarcoma AT liuhuancai currentstatusandprospectsoftargetedtherapyforosteosarcoma AT zhoushuanhu currentstatusandprospectsoftargetedtherapyforosteosarcoma |